Cover Image

Frequency of dihydropyrimidine dehydrogenase and UDP-glucuronosyltransferase 1A1 variants in cancer patients requiring chemotherapy: A single-center study in southern India

Abstract Background: Cancer treatment using drugs metabolized by the enzymes dihydropyrimidine dehydrogenase (DPYD) and UDP-glucuronosyltransferase 1A1 (UGT1A1) results in adverse effects for some patients. This is frequently reported in cancer patients undergoing therapy with 5-fluorouracil, capeci...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kevin Nischay Gangavarapu (Author), Nandini Shyamali Bora (Author), Srinivas Maddali (Author), Qurratulain Hasan (Author)
Format:	Book
Published:	Golestan University Of Medical Sciences, 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular biology of glucose-6-phosphate dehydrogenase and UDP-glucuronosyltransferase 1A1 in the development of neonatal unconjugated hyperbilirubinemia
by: Yi-Li Hung, et al.
Published: (2024)

Quantitative analysis of the UDP‐glucuronosyltransferase transcriptome in human tissues
by: Lucas Zhou, et al.
Published: (2023)

Structure and protein-protein interactions of human UDP-glucuronosyltransferases
by: Ryoichi Fujiwara, et al.
Published: (2016)

Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
by: Xuewei Cheng, et al.
Published: (2017)

Dysregulated hepatic UDP-glucuronosyltransferases and flavonoids glucuronidation in experimental colitis
by: Wanying Zeng, et al.
Published: (2022)

Effects of variation status and enzyme activity for UDP-glucuronosyltransferase 1A1 gene on neonatal hyperbilirubinemia
by: May-Jen Huang, et al.
Published: (2020)

Age-dependent Hepatic UDP-glucuronosyltransferase Gene Expression and Activity in Children
by: Elizabeth Neumann, et al.
Published: (2016)

Inhibitory effects of tanshinones towards the catalytic activity of UDP-glucuronosyltransferases (UGTs)
by: Xu-Xin Zhang, et al.
Published: (2017)

Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events
by: Theodore J. Wigle, et al.
Published: (2021)

Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis.
by: Alexander F Flynn, et al.
Published: (2019)

Association of NQO2 With UDP-Glucuronosyltransferases Reduces Menadione Toxicity in Neuroblastoma Cells
by: Monivan Chhour, et al.
Published: (2021)

Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen
by: Huma Mehboob, et al.
Published: (2017)

Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase
by: Jihyun Kang, et al.
Published: (2022)

17β-Estradiol up-regulates UDP-glucuronosyltransferase 1A9 expression via estrogen receptor α
by: Sung-joon Cho, et al.
Published: (2016)

Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances
by: Yun Sheng, et al.
Published: (2021)

Discovery and Characterization of the Key Constituents in Ginkgo biloba Leaf Extract With Potent Inhibitory Effects on Human UDP-Glucuronosyltransferase 1A1
by: Hui-Lin Pang, et al.
Published: (2022)

UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data
by: Apolonia Novillo, et al.
Published: (2018)

Dihydropyrimidine dehydrogenase deficiency as a cause of fatal 5-Fluorouracil toxicity
by: Shiraz S. Fidai, et al.
Published: (2018)

Human UDP-Glucuronosyltransferase 2B4 and 2B7 Are Responsible for Naftopidil Glucuronidation in Vitro
by: Xia-Wen Liu, et al.
Published: (2018)

Exploring the Metabolism of Loxoprofen in Liver Microsomes: The Role of Cytochrome P450 and UDP-Glucuronosyltransferase in Its Biotransformation
by: Riya Shrestha, et al.
Published: (2018)

Tetrahydrofurofuranoid Lignans, Eudesmin, Fargesin, Epimagnolin A, Magnolin, and Yangambin Inhibit UDP-Glucuronosyltransferase 1A1 and 1A3 Activities in Human Liver Microsomes
by: Ria Park, et al.
Published: (2021)

Improving single nucleotide polymorphisms genotyping accuracy for dihydropyrimidine dehydrogenase testing in pharmacogenetics
by: Annalaura Montella, et al.
Published: (2024)

Identification of Catalposide Metabolites in Human Liver and Intestinal Preparations and Characterization of the Relevant Sulfotransferase, UDP-glucuronosyltransferase, and Carboxylesterase Enzymes
by: Deok-Kyu Hwang, et al.
Published: (2019)

Pharmacokinetic drug-drug interactions of JBPOS0101 mediated by cytochrome P450 3A4 and UDP‐glucuronosyltransferases
by: Sejung Hwang, et al.
Published: (2024)

INTRODUCTION OF AN N-GLYCOSYLATION SITE INTO UDP-GLUCURONOSYLTRANSFERASE 2B3 ALTERS ITS SENSITIVITY TO CYTOCHROME P450 3A1-DEPENDENT MODULATION
by: Tatsuro Nakamura, et al.
Published: (2016)

A pilot study using immunohistochemical staining to characterize dihydropyrimidine dehydrogenase expression in keratinocyte neoplasms
by: Ogechi Ikediobi, MD, PhD, et al.
Published: (2023)

The pharmaceutical excipient PEG400 affect the absorption of baicalein in Caco‐2 monolayer model by interacting with UDP‐glucuronosyltransferases and efflux transport proteins
by: Siyuan Cao, et al.
Published: (2022)

Metabolism of 2,3-Dehydrosilybin A and 2,3-Dehydrosilybin B: A Study with Human Hepatocytes and Recombinant UDP-Glucuronosyltransferases and Sulfotransferases
by: Jiří Vrba, et al.
Published: (2021)

Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time
by: Marieke J.H. Coenen, PhD, et al.
Published: (2019)

A novel large intragenic DPYD deletion causing dihydropyrimidine dehydrogenase deficiency: a case report
by: Anna Malekkou, et al.
Published: (2024)

Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite
by: Shuaibing Liu, et al.
Published: (2021)

Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6∗2, 1A7∗12, 1A8∗3, 1A9∗3, 2B7∗2, and 2B15∗2) in a
by: Khalid M. Alkharfy, et al.
Published: (2017)

Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or Capecitabine
by: Mahshid Mohammadian, et al.
Published: (2019)

Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
by: Con Murphy, et al.
Published: (2018)

Synthesis, antifungal activity, and QSAR studies of 1,6-dihydropyrimidine derivatives
by: Chirag Rami, et al.
Published: (2013)

Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug-drug interactions
by: Zifei Qin, et al.
Published: (2020)

Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis
by: Nicolas Laures, et al.
Published: (2022)

Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
by: Eoin O'Farrell, et al.
Published: (2019)

Integrate thermostabilized fusion protein apocytochrome b562RIL and N-glycosylation mutations: A novel approach to heterologous expression of human UDP-glucuronosyltransferase (UGT) 2B7
by: Jia Xue, et al.
Published: (2022)

Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study
by: Paula Soria-Chacartegui, et al.
Published: (2021)